Ravi RamjeesinghMD, PhD, FRCPC

Associate professor


Phone: 902-473-6106
Fax: 902-473-6186
Mailing Address: 
Division of Medical Oncology
QEII - Bethune Building
Suite 460 Bethune Building
1276 South Park Street
Halifax, NS B3H 2Y9
Research Topics:
  • health service delivery
  • translational research
  • medical oncology education
  • breast cancer
  • gastrointestinal cancers


  • Translational research fellowship, CAMO-CIHR Fellowship Award and AACR Scholar-in Training Award (Queen’s University)
  • Medical oncology residency (Queen’s University)
  • Internal medicine residency (Queen’s University)
  • MD (University of Toronto)
  • PhD (University of Toronto)
  • BSc (University of Toronto)


Dr. Ramjeesingh holds an MD and PhD from the University of Toronto and completed residency training in internal medicine and medical oncology through Queen’s University. He then undertook a two-year clinical trial methodology and translational research fellowship with the NCIC Clinical Trials Group at Queen’s. His work focused on the appropriate timing of administration of adjuvant chemotherapy to patients with breast cancer.

Clinical and research interests

Dr. Ramjeesingh focuses his clinical practice on treatment of breast cancer, gastrointestinal cancers, including hepatocellular carcinoma, pancreatic and cholangiocarcinomas, and melanoma. His primary research interests include translational and health services research, and oncology education of residents and medical students.

Selected publications

  • Ramjeesingh, R., Orr, C., Bricks, CS., Hopman, WM., and Hammad, N. (2016). A retrospective study on the role of diabetes and metformin in colorectal cancer disease survival. Current Oncology, 23(2): e116-122.
  • Ramjeesingh, R., Meyer, RM., Brouwers, M., Booth, CM. (2013). Alignment of practice guidelines with targeted therapy drug funding policies in Ontario. Current Oncology, 20(1): e21-33.
  • Ramjeesingh, R., Quan, ML., Gardner, S., Holloway, CM. (2009). Prediction of involvement of sentinel and non-sentinel lymph nodes in a Canadian population with breast cancer. Canadian Journal of Surgery, 52: 23-30.
  • Ramjeesingh, RA., Leung, R., and Siu, C-H. (2003). Interleukin-8 secreted by endothelial cells induces chemotaxis of melanoma cells through the chemokine receptor CXCR1. FASEB, 17: 1292-1294.
  • Voura, EB., Ramjeesingh, RA., Montgomery, AM., Siu, C-H. (2001). Involvement of integrin a(v)b(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol. Bio. Cell, 12: 2699-2710.

Selected awards and honours

  • Medical Oncology Teacher of the Year, Dalhousie University (2015–2016)
  • AACR Scholar-in-Training Award (2014)
  • CAMO-CIHR Fellowship Award (2013–2015)
  • Internal Medicine Professors Award (2011)
  • McCormick Scholarship for Radiation Oncology (2008)


  • Staff physician, Division of Medical Oncology, Nova Scotia Cancer Centre, QEII Health Sciences Centre, Halifax (2015–present)
  • Sub-investigator for Dr. Anne Ellis (allergy & immunology), Queen’s University and Kingston General Hospital, Kingston (2013–2015)


  • American Society of Clinical Oncology
  • American Association of Cancer Research
  • Canadian Association of Medical Oncologists
  • Canadian Medical Association
  • Doctors Nova Scotia
Referring physician?

View triage criteria, referral processes, wait times and contact information for Medical Oncology